Indian schizophrenia drugs market is projected to grow at a significant CAGR of 4.0% during the forecast period (2020-2026). The major contributors in the market are the female population suffering from mental health issues in the country. There is no gender difference in schizophrenia; however, a stress and mental health are some factors leads to schizophrenia. In India, women face a lot of problems in India, especially in relation to pregnancy, marriage, childbirth, and menopause. There is no clear trend has been stated till date of schizophrenia with mortality, although suicides seem to be more in women with schizophrenia in India.
Browse the full report description of "Indian Schizophrenia Drugs Market Size, Share & Trends Analysis Report by Therapeutic Class (Second-Generation Antipsychotics, Third-Generation Antipsychotics, and Others) and by Treatment (Oral and Injectables) and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/indian-schizophrenia-drugs-market
Moreover, the rising healthcare spending and awareness for metal health in the country is leading to the schizophrenia drugs market growth in India. A number of mental healthcare institutions have established in the period of past 5 years. Therefore, a significant market is expected in India during the forecast period. Women are expected to contribute significantly in the market in India. The Government of India is taking several steps to monitor and control the mental disorders in the country. Moreover, the government regularly conducts surveys for mental health in India, which in turn, assist in the growth of the schizophrenia drug market in the country.
Market Coverage
Report Elements |
Details |
Study Period |
2019-2026 |
Base year |
2019 |
Forecast period |
2020-2026 |
Segments Covered |
By Therapeutic Class and By Treatment |
Key Companies Profiled |
Allergan PLC, Catalent, Inc., Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc. |
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
Indian Schizophrenia Drugs Market – Segmentation
By Therapeutic Class
By Treatment
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/indian-schizophrenia-drugs-market